Financial News
Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales
July 21, 2021 at 10:43 AM EDT
Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
